UNSPSC 51162613: Butamirate citrate

This classification denotes an antitussive agent with the molecular formula C18H29NO3.C6H8O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 67HP51L98R, chemically known as butyric acid, 2-phenyl-, 2-(2-(diethylamino)ethoxy)ethyl ester, citrate but more generally known as butamirate citrate, which bears US NIH Compound Identifier 28891. European Medicines Agency schedules Butamirate citrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00911MIG.

Most nations, for tariff and trade purposes, schedule butamirate citrate under HS 29221980 and SITC 51461. As of Q4 2014, BUTAMIRATE CITRATE remains US FDA's Preferred Term for this commodity. SMILES: CCC(C1CCCCC1)C(=O)OCCOCCN(CC)CC.C(C(=O)O)C(CC(=O)O)(C(=O)O)O.

UNSPSC 51162613 Butamirate citrate is a Commodity code that does not reflect the work actually being solicited under it in recent state and local opportunities. The code's nominal scope is a single active pharmaceutical ingredient; however, the recent opportunities tagged to this code involve procurement of finished naloxone products and drug deactivation systems, as well as generic multi-source pharmaceuticals and over-the-counter products distributed through wholesale channels. The mismatch suggests either a data-entry error in the tagging or a misalignment between the code's narrow pharmaceutical-ingredient definition and how state and local procurement offices are using it to solicit broader pharmaceutical supply.

The two recent opportunities show activity across different issuing-body types and geographic regions. Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries, with responses due July 26, 2023 (an apparent date error in the source). The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 on January 20, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and over-the-counter products across participating state and local government facilities in Minnesota and Oregon, with responses due March 26, 2026. The code shows limited recent activity, and the alignment between the Commodity code definition and actual procurement work is weak.